Akeso: We’re The Leaders In Bispecific Cancer Immunotherapies

 
• By Andrew McConaghie
  
The Shenzhen middle channel bridge in the Pearl river delta connects the cities of Shenzen and Zhongshan, where Akeso is headquartered. (Shutterstock)
In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

SpotifyApple PodcastsWebsite

More from Innovation

More from C-Suite Speaks